Imaging the Head:Functional Imaging
JNNP 58:132-144, Sawle,G.V., 1995
Neonatal Seizures
NEJM 388:1692-1700, Ropper.A.H., 2023
Clinicopathologic Conference, Seizure from Neurocysticercosis
NEJM 385:1894-1902, Case 34-2021, 2021
Clinicopathologic Conference, Chronic Meningoencephalitis Consistent with Rasmussens Encephalitis
NEJM 371:1737-1746, Case 34-2014, 2014
Acute Symptomatic Seizures
The Neurologist 18:109-119, Beleza,P., 2012
Autoimmune Epilepsy
Arch Neurol 69:582-593,565, Quek, A.M.L.,et al, 2012
Generalised Periodic Discharges in the Critically Ill
Neurol 79:1951-1960,1940, Foreman, B.,et al, 2012
Antibodies to Glutamic Acid Decarboxylase Define a Form of Limbic Encephalitis
Ann Neurol 67:470-478, Malter,M.P., et al, 2010
Post-Transplant Acute Limbic Encephalitis: Clinical Features and Relationship to HHV6
Neurol 69:156-165, Seeley,W.W.,et al, 2007
Clinical Features of Status Epilepticus in Patients with HIV Infection
Neurol 65:314-316, Lee,K.C.,et al, 2005
Tapeworms and Seizures--Treatment and Prevention
NEJM 350:215-217, Maguire,J.H., 2004
A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis
NEJM 350:249-258,215,280, Garcia,H.H.,et al, 2004
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Medical Causes of Seizures
Lancet 352:383-390, Delanty,N.,et al, 1998
Adult-Onset Temporal Lobe Epilepsy Associated with Smoldering Herpes Simplex 2 Infection
Neurol 48:425-430, Cornford,M.E.&McCormick,G.F., 1997
Seizures and Epilepsy in the Elderly
Arch Int Med 157:605-617, Thomas,R.J., 1997
Clinicopath Conf
Dysembryoplastic Neuroepithelial Tumor, Case 14-1997, NEJM 336:1373-1379997., , 1997
Seizures in Medically Complex Patients
Epilepsia 38:S55-S59, Boggs,J.G., 1997
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Comparison of Ictal SPECT and Interictal PET in the Presurgical Evaluation of Temporal Lobe Epielspy
Ann Neurol 37:738-745, Ho,S.S.,et al, 1995
Prognostic Factors for Seizure Recurrence after Withdrawal of Antiepileptic Drugs in Patients with Neurocysticercosis
Neurol 44:1706-1709, DelBrutto,O.H., 1994
Clinical Charact & Predictive Factors in 98 Pts with Complex Partial Seizures Treated with Temporal Resection
Arch Neurol 51:1008-1013, Salanova,V.,et al, 1994
Status Epilepticus at an Urban Public Hospital in the 1980s
Neurol 43:483-488, Lowenstein,D.H.&Alldredge,B.K., 1993
The Course of Seizures after Treatment for Cerebral Cysticercosis
NEJM 327:696-701, Vazquez,V.&Sotelo,J., 1992
Characteristics of Intractable Seizures Following Meningitis and Encephalitis
Neurol 42:1513-1518, Marks,D.A.,et al, 1992
Clinical Uses of Intravenous Immunoglobulins
Ann Int Med 112:278-292, Berkman,S.A.,et al, 1990
Lessons in the Surgical Treatment of Epilepsy
Editorial, Lancet 2:366-3671989., , 1989
New-Onset Seizures Associated with Human Immunodeficiency Virus Infection: Causation and Clinical Features in 100 Cases
Am J Med 87:173-177, Holtzman, D.M.,et al, 1989
Drug Resistant Epilepsy in a 61-Year-Old Man with Abnormal MRI Brain Findings and Management with Vagal Nerve Stimulator
Neurol 100:1111-1116, Mankad,J.P. & Lavingia,J.R., 2023
The SANAD II Study of the Effectiveness and Cost-Effectiveness of Valproate Versus Levetiracetam for Newly Diagnosed Generalised and Unclassifiable Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1375-1386, Marson, A.,et al, 2021
Vagus Nerve Stimulation and Seizure Outcomes in Pediatric Refractory Epilepsy
Neurol 96:1041-1051, Jain, P. & Arya, R., 2021
Initial Management of Seizure in Adults
NEJM 385:251-263, Smith, P.E.M., 2021
Safety and Efficacy of Coma Induction Following First-Line Treatment in Status Epilepticus
Neurol 97:e564-e576, DeStefano, P.,et al, 2021
Antiseizure Medication Withdrawal in Seizure-Free Patients: Practice Advisory Update Summary
Neurol 97:1072-1081, Gloss, D.,et al, 2021
Epilepsy in Older People
Lancet 395:735-748, Sen, A.,et al, 2020
Deprescribing in Epilepsy
JAMA Neurol 77:673-674, Terman, S.W.,et al, 2020
Choosing Anticonvulsant Medications to Manage Status Epilepticus
NEJM 382:2569-2572, Wu, K., 2020
FDA Approves Fenfluramine for Treatment of Seizures Associated with Dravet Syndrome
FDA June2020, , 2020
Efficacy and Safety of Adjunctive Lacosamide in the Treatment of Primary Generalised Tonic-Clonic Seizures: A Double-Blind, Randomised, Placebo-Controlled Trial
JNNP 91:1067-1075, Vossler, D.G.,et al, 2020
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019
Cannabidiol in Patients with Seizures Associated with Lennox-Gastaut Syndrome (GWPCARE4): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial
Lancet 391:1085-1096, Thiele, E.A.,et al, 2018
Efficacy and Tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy
Neurol 91:82-90, Kanner, A.M.,et al, 2018
Efficacy and Tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy
Neurol 91:74-81, Kanner, A.M.,et al, 2018
Antiepileptic Drug Treatment After An Unprovoked First Seizure
Neurol 91:e1429-e1439,684, Bao, E.L.,et al, 2018
Tocilizumab Treatment for New Onset Refractory Status Epilepticus
Ann Neurol 84:940-945, Jun, J.,et al, 2018
Switching the Manufacturer of Antiepileptic Drugs is Associated with Higher Risk of Seizures: A Nationwide Study of Prescription Data in Germany
Ann Neurol 84:918-925, Lang, J.D.,et al, 2018
Successful Management of Super-Refractory Status Epilepticus with Thalamic Deep Brain Stimulation
Ann Neurol 81:142-146, Lehtimaki, K.,et al, 2017
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
NEJM 376:2011-2020, Devinsky, O.,et al, 2017